Dr. Ismail-Beigi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1971 - 1972
- University of California (San Francisco)Residency, Internal Medicine, 1968 - 1971
- Johns Hopkins UniversityResidency, Internal Medicine, 1967 - 1968
- Johns Hopkins University School of MedicineInternship, Transitional Year, 1966 - 1967
- Johns Hopkins University School of MedicineClass of 1966
Certifications & Licensure
- OH State Medical License 1993 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 1819 citationsEffects of combination lipid therapy in type 2 diabetes mellitus.Henry N. Ginsberg, Laura C. Lovato, Lawrence A. Leiter, Peter E. Linz, John B. Buse
The New England Journal of Medicine. 2010-04-29 - 15 citationsImpaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort studyNahid Hashemi Madani, Faramarz Ismail-Beigi, Hossein Poustchi, Mahdi Nalini, Sadaf G. Sepanlou
BMC Cardiovascular Disorders. 2020-03-05 - 12 citationsShape of the OGTT glucose response curve: relationship with β-cell function and differences by sex, race, and BMI in adults with early type 2 diabetes treated with met...Kristina M. Utzschneider, Naji Younes, Neda Rasouli, Joshua I. Barzilay, Mary Ann Banerji
BMJ Open Diabetes Research & Care. 2021-09-01
Press Mentions
- Researchers Call for Paradigm Shift in Type 2 Diabetes TreatmentJune 20th, 2017
- ACCORD Analyses Find a Few Faint Glimmers of HopeJune 29th, 2010
Grant Support
- Novel PET Imaging Of Glucose TransportNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- AccordNational Heart, Lung, And Blood Institute2010
- Carbohydrate Metabolic PathwaysNational Institute Of Diabetes And Digestive And Kidney Diseases2007
- Regulation Of GLUT 1 FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
- Thyroidal Regulation Of Cardiac Sodium/Potassium Atpase Expression And EnergeticsNational Heart, Lung, And Blood Institute2002–2005
- Regulation Of GLUT1 Gene Expression By HypoxiaNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
- Thyroid Hormone Control Of Cardiac Sodium/Potassium Atpase ExpressionNational Heart, Lung, And Blood Institute1996–2000
- Regulation Of GLUT1 Glucose Transporter ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1996
- Physiological Regulation Of NA 1 K-AtpaseNational Institute Of General Medical Sciences1992
- Physiological Regulation Of NA, K-AtpaseNational Institute Of General Medical Sciences1988–1992
- Physiological Control Of Myocardial Na,K-Pump ExpressionNational Heart, Lung, And Blood Institute1988–1991
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: